The Current Ratio as of December 2025 (TTM) for Lytix Biopharma AS (LYTIX.OL) is 5.85

According to Lytix Biopharma AS’s latest financial reports and current stock price. The company's current Current Ratio is 5.85. This represents a change of 40.12% compared to the average of 4.18 of the last 4 quarters.

Lytix Biopharma AS (LYTIX.OL) Historical Current Ratio (quarterly & annually)

How has LYTIX.OL Current Ratio performed in the past?

The mean historical Current Ratio of Lytix Biopharma AS over the last ten years is 6.16. The current 5.85 Current Ratio has changed 9.39% with respect to the historical average. Over the past ten years (40 quarters), LYTIX.OL's Current Ratio was at its highest in in the September 2021 quarter at 24.26. The Current Ratio was at its lowest in in the September 2020 quarter at 0.

Lytix Biopharma AS (LYTIX.OL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Lytix Biopharma AS Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lytix Biopharma AS (LYTIX.OL) Average Current Ratio

How has LYTIX.OL Current Ratio performed in the past?

The current Current Ratio of Lytix Biopharma AS (LYTIX.OL) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Lytix Biopharma AS (LYTIX.OL) Current Ratio vs. Peers

How is LYTIX.OL’s Current Ratio compared to its peers?

Lytix Biopharma AS’s Current Ratio is less than Nykode Therapeutics AS (15.21), greater than Hofseth BioCare ASA (0.96), greater than Navamedic ASA (1.30), greater than BerGenBio ASA (4.39), greater than Arctic Bioscience AS (0.83), greater than PCI Biotech Holding ASA (2.94), greater than ContextVision AB (publ) (4.12), greater than Gentian Diagnostics ASA (5.47), less than Thor Medical ASA (8.87), greater than Lifecare AS (3.34),

Build a custom stock screener for Lytix Biopharma AS (LYTIX.OL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lytix Biopharma AS using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lytix Biopharma AS (LYTIX.OL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lytix Biopharma AS or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.